Strategic Market Share Analysis of Opportunities and Risks for Australian Pharmaceutical Companies
Abstract
Companies have the dreams that one day they would grow and become a global entity with high returns. Several Australian companies such as Amcor, Telstra and Wesfarmers have been successful whereas others have tried and not succeeded for different reasons. There are usually several factors to put under consideration and many crossroads on the road to success of becoming a profitable multinational company. Whichever way a company decides to follow, clear strategies are usually paramount. This paper presents a comparative analysis of the opportunities and risks of expanding to either China or Africa. The paper an analysis the opportunities and risks that Australian pharmaceutical companies looks into in its aspiration to expand its market base after sales recorded indicated a stall. For sustainability, Australian pharmaceutical companies looks into expanding its products to either China or Africa, which are foreign markets. The paper further expounds on the factors that favor market entry into the foreign market and makes a justification for the preferred choice.
Keywords: Market Share Analysis, Opportunities and Risks, China, Africa & Australian Pharmaceutical Companies.
References
Brandt, L. and Morrow, P.M., 2017. Tariffs and the Organization of Trade in China. Journal of International Economics, 104, pp.85-103.
Best’s Country Risk Report, 2018. pp. 1-2.
Brink, C.H., 2017. Measuring political risk: risks to foreign investment. Routledge. Butler, A., 2017. Contemporary South Africa. Macmillan International Higher Education.
David, H., Dorn, D., Hanson, G.H., Pisano, G.P. and Shu, P., 2016. Foreign Competition and Domestic Innovation: Evidence from US Patents.
Eze, M., 2016. Intellectual history in contemporary South Africa. Springer.
Farquhar, J., 2018. Knowing practice: The clinical encounter of Chinese medicine. Routledge.
Fine, B., 2018. The political economy of South Africa: From minerals-energy complex to industrialization. Routledge.
Geng, Y., Tian, X., Sarkis, J. and Ulgiati, S., 2017. China-USA trade: indicators for equitable and environmentally balanced resource exchange. Ecological Economics, 132, pp.245-254.
Haggard, Stephan, and Robert R. Kaufman. 2018. The political economy of democratic transitions. Princeton University Press.
Lanteigne, M., 2015. Chinese foreign policy: an introduction. Routledge.
Li, Y.J. and Lyu, Z.D., 2018. Research on Chinese Pharmaceutical Industry Based on Multivariate Statistics. In Basic & Clinical Pharmacology & Toxicology (Vol. 122, Pp. 49-49). 111 River St, Hoboken 07030-5774, NJ USA: Wiley.
Lu, N., 2018. The dynamics of foreign-policy decision-making in China. Routledge.
Lundqvist, B., Minssen, T. and Pierce, J., 2016. Competition Law and IP Rights in Pharmaceuticals and Biotechnology (forthcoming).
Ravenhill, J., 2017. Global political economy. Oxford University Press.
Roux, A., 2016. Everyone’s Guide to the South African Economy 12th edition. Penguin Random House South Africa.
World Bank Group, 2017. World development indicators 2017. World Bank Publications. World Trade Organization, 2017. International trade statistics. World Trade Organization.
Zweig, D., 2018. Internationalizing China: domestic interests and global linkages. Cornell University Press.
